About NAT Diagnostics
NAT Diagnostics is a company based in San Diego (United States) founded in 2015 was acquired by Becton Dickinson in May 2020.. NAT Diagnostics has raised $4.41 million across 2 funding rounds from investors including BD. NAT Diagnostics operates in a competitive market with competitors including Cepheid, Prenetics, Karius, Day Zero Diagnostics and OpGen, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.41 M (USD)
in 2 rounds
-
Latest Funding Round
$1.5 M (USD), Seed
Nov 16, 2017
- Investors
-
Employee Count
Employee Count
-
Acquired by
Becton Dickinson
(May 15, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NAT Diagnostics
NAT Diagnostics has successfully raised a total of $4.41M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.5M
-
First Round
First Round
(11 Sep 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Seed - NAT Diagnostics | Valuation |
investors |
|
| Sep, 2015 | Amount | Seed - NAT Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NAT Diagnostics
NAT Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BD. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BD is recognized for providing innovative medical technology solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NAT Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NAT Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nat Diagnostics Comparisons
Competitors of NAT Diagnostics
NAT Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Prenetics, Karius, Day Zero Diagnostics and OpGen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of molecular diagnostic testing solutions
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| domain | founded_year | HQ Location |
Food safety technologies are provided for pathogen identification.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nat Diagnostics
Frequently Asked Questions about NAT Diagnostics
When was NAT Diagnostics founded?
NAT Diagnostics was founded in 2015.
Where is NAT Diagnostics located?
NAT Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is NAT Diagnostics a funded company?
NAT Diagnostics is a funded company, having raised a total of $4.41M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.91M, raised on Sep 11, 2015.
What does NAT Diagnostics do?
NAT Diagnostics was founded in 2015 and is based in San Diego, United States. Operations center on the development of point-of-care diagnostic devices for infectious diseases. Instrumentation is designed to provide results in 10 minutes, with costs under 800, and to meet CLIA-waiver standards while requiring no special training. Future efforts will target antibiotic resistance and oncology applications.
Who are the top competitors of NAT Diagnostics?
NAT Diagnostics's top competitors include Cepheid, Prenetics and Clear Labs.
Who are NAT Diagnostics's investors?
NAT Diagnostics has 1 investor. Key investors include BD.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.